Activity study of a hydroxynaphthoquinone fraction from Arnebia euchroma in experimental arthritis

Fitoterapia

Volumn 83, Issue 7, 2012, Pages 1226-1237

  Fan, Huaying ^a   Yang, Mingyan ^b   Che, Xin ^a,b   Zhang, Ziliang ^a,c   Xu, Hui ^a,b   Liu, Ke ^a,b   Meng, Qinggang ^d  

^a YANTAI UNIVERSITY   (China)

^b Shandong Target Drug Research Co Ltd   (China)

^c JILIN UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Adjuvant induced arthritis; Analgesic; Anti inflammation; Arnebia euchroma (Royle) Johnst; Bovine type II collagen induced arthritis; Hydroxynaphthoquinones

Indexed keywords

ANTIRHEUMATIC AGENT; ARNEBIA EUCHROMA EXTRACT; COLLAGEN TYPE 2; ETANERCEPT; FREUND ADJUVANT; HYDROXYNAPHTHOQUINONE; INTERLEUKIN 1BETA; PLANT EXTRACT; PREDNISONE ACETATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARNEBIA EUCHROMA; ARTICLE; BODY WEIGHT; BONE INJURY; CARTILAGE INJURY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; MALE; MEDICINAL PLANT; MOUSE; NOCICEPTION; NONHUMAN; PAW EDEMA; POLYARTHRITIS; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BONE DISEASES; BORAGINACEAE; CARTILAGE DISEASES; CATTLE; COLLAGEN TYPE II; EDEMA; FREUND'S ADJUVANT; HOT TEMPERATURE; IMMUNOGLOBULIN G; INFLAMMATION; INTERLEUKIN-1BETA; JOINT DISEASES; MALE; NAPHTHOQUINONES; PHYTOTHERAPY; PLANT EXTRACTS; PREDNISONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

ARNEBIA EUCHROMA; BOVINAE;

EID: 84865460374     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2012.06.011     Document Type: Article

References (28)

1. L. Klareskog, A. Catrina, and S. Paget Rheumatoid arthritis Lancet 373 2009 659 672
2. J.S. Smolen, D. Aletaha, M. Koeller, M.H. Weisman, and P. Emery New therapies for treatment of rheumatoid arthritis Lancet 370 2007 1861 1874
3. G.J. Tobón, P. Youinou, and A. Saraux The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis Autoimmun Rev 9 2010 288 292
4. Y.P. Goekoop-Ruiterman, J.K. de Vries-Bouwstra, C.F. Allaart, D. van Zeben, P.J. Kerstens, and J.M. Hazes Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial Arthritis Rheum 52 2005 3381 3390
5. P. xZhang, L. Qin, and G. Zhang The potential application of nicotinic acetylcholine receptor agonists for the treatment of rheumatoid arthritis Inflamm Res 59 2010 415 417
6. Z.S. Huang, M. Zhang, L. Ma, and L.Q. Gu A survey of chemical and pharmacologic studies on Zicao Nat Prod Res Dev 12 1999 73 82
7. V.P. Papageorgiou, A.N. Assimopoulou, E.A. Couladouros, D. Hepworth, and K.C. Nicolaou The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products Angew Chem Int Ed 38 1999 270 300
8. B. Singh, M.K. Sharma, P.R. Meghwal, P.M. Sahu, and S. Singh Anti-inflammatory activity of shikonin derivatives from Arnebia hispidissima Phytomedicine 10 2003 375 380
9. B. Singh, P.M. Sahu, S.C. Jain, and S. Singh Estimation of naphthaquinones from Arnebia hispidissima (Lehm.) DC. in vivo and in vitro. I. Anti-inflammatory screening Phytother Res 18 2004 154 159
10. Q. Dai, J. Fang, and F. Zhang Dual role of shikonin in early and late stages of collagen type II arthritis Mol Biol Rep 36 2009 1597 1604
11. Y.O. Kim, S.J. Hong, and S.V. Yim The efficacy of shikonin on cartilage protection in a mouse model of rheumatoid arthritis Korean J Physiol Pharmacol 14 2010 199 204
12. S. Tanaka, M. Tajlma, M. Tsukada, and M. Tabata A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin J Nat Prod 49 1986 466 469
13. H.Q. Zhao, J.F. Liu, and K. Liu Hydroxynaphthoquinone compounds from Arnebia euchroma and their inhibitory activities of phosphodiesterase 4 Chinese J Exp Traditional Med Formulae 16 2010 96 99
14. H.O.J. Collier, L.C. Dinneen, C.A. Johnson, and C. Schneider The abdominal constriction and its suppression by analgesic drugs in the mouse Br J Pharmacol Chemother 32 1968 295 310
15. E.N. Duman, M. Kesim, M. Kadioglu, C. Ulku, N.I. Kalyoncu, and E. Yaris Effect of gender on antinociceptive effect of paroxetine in hot plate test in mice Prog Neuropsychopharmacol 30 2006 292 296
16. J. Milano, S.M. Oliveira, M.F. Rossato, P.D. Sauzem, P. Machado, and P. Beck Antinociceptive effect of novel trihalomethy1-substituted pyrazoline methyl esters in formalin and hot-plate tests in mice Eur J Pharmacol 581 2008 86 96
17. S. Cuzzocrea, E. Mazzon, R.D. Paola, T. Genovese, C. Muia, and A.P. Caputi Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis Arthritis Rheum 52 2005 1929 1940
18. G.M. Deng, and M. Lenardo The role of immune cells and cytokines in the pathogenesis of rheumatoid arthritis Drug Discov Today Dis Mech 3 2006 163 168
19. K. Redlich, S. Hayer, R. Ricci, J.P. David, M. Tohidast-Akrad, and G. Kollias Osteoclasts are essential for TNF-α-mediated joint destruction J Clin Invest 110 2002 1419 1427
20. E. Woode, E. Boakye-Gyasi, C.A. Danquah, C. Ansah, and M. Duwiejua Anti-arthritis effects of Palisota hirsute K. Schum. leaf extract in Freund's adjuvant-induced arthritis in rats Int J Pharm 5 2009 181 190
21. A.M. Bendele Animal models of rheumatoid arthritis J Musculoskelet Neuronal Interact 1 2001 377 385
22. D.M. Findlay, and D.R. Haynes Mechanisms of bone loss in rheumatoid arthritis Mod Rheumatol 15 2005 232 240
23. T. Yang, Z. Wang, F. Wu, J. Tan, Y. Shen, and E. Li A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis PLoS Comput Biol 6 2010 1000669
24. T. Muchamuel, M. Basler, M.A. Aujay, E. Suzuki, K.W. Kalim, and C. Lauer A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis Nat Med 15 2009 781 787
25. L.W. Moreland, and J.R. O'Dell Glucocorticoids and rheumatoid arthritis: back to the future Arthritis Rheum 46 2002 2553 2563
26. J.R. O'Dell Therapeutic strategies for rheumatoid arthritis N Engl J Med 350 2004 2591 2602
27. R.A. Ribeiro, M.L. Vale, S.M. Thomazzi, A.B.P. Paschoalato, S. Poole, and S.H. Ferreira Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice Eur J Pharmacol 387 2000 111 118
28. E.C. Rankin, E.H. Choy, D. Kassimos, G.H. Kingsley, A.M. Sopwith, and D.A. Isenberg The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis Br J Rheumatol 34 1995 334 342